ScoreWhy is Fujian Wanchen Biotechnology Group Co., Ltd. ?
1
With a growth in Net Profit of 193.12%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 8 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 3,759.4 MM
- ROCE(HY) Highest at 105.36%
- DEBT-EQUITY RATIO (HY) Lowest at -167.49 %
2
With ROE of 148.97%, it has a fair valuation with a 13.97 Price to Book Value
- Over the past year, while the stock has generated a return of -0.70%, its profits have risen by 225.7% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Fujian Wanchen Biotechnology Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Other Agricultural Products should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fujian Wanchen Biotechnology Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Fujian Wanchen Biotechnology Group Co., Ltd.
-3.41%
12.45
50.75%
China Shanghai Composite
16.78%
1.40
13.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
165.96%
EBIT Growth (5y)
107.91%
EBIT to Interest (avg)
9.86
Debt to EBITDA (avg)
0.40
Net Debt to Equity (avg)
-1.12
Sales to Capital Employed (avg)
11.95
Tax Ratio
36.09%
Dividend Payout Ratio
13.52%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.42%
ROE (avg)
20.88%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
13.97
EV to EBIT
6.46
EV to EBITDA
6.13
EV to Capital Employed
-15.57
EV to Sales
0.43
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
148.97%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend42What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 3,759.4 MM
ROCE(HY)
Highest at 105.36%
DEBT-EQUITY RATIO
(HY)
Lowest at -167.49 %
DEBTORS TURNOVER RATIO(HY)
Highest at 708.67 times
NET SALES(Q)
Highest at CNY 16,634.41 MM
OPERATING PROFIT(Q)
Highest at CNY 1,181.72 MM
PRE-TAX PROFIT(Q)
Highest at CNY 1,284.15 MM
NET PROFIT(Q)
Highest at CNY 629.78 MM
RAW MATERIAL COST(Y)
Fallen by -23.39% (YoY
EPS(Q)
Highest at CNY 3.12
-4What is not working for the Company
INTEREST(Q)
Highest at CNY 20.44 MM
Here's what is working for Fujian Wanchen Biotechnology Group Co., Ltd.
Operating Cash Flow
Highest at CNY 3,759.4 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 16,634.41 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Net Sales
At CNY 16,634.41 MM has Grown at 53.73%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 1,181.72 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 1,284.15 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 1,284.15 MM has Grown at 145.25%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 629.78 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Profit
At CNY 629.78 MM has Grown at 193.12%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Debt-Equity Ratio
Lowest at -167.49 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 708.67 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
EPS
Highest at CNY 3.12
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -23.39% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Fujian Wanchen Biotechnology Group Co., Ltd.
Interest
At CNY 20.44 MM has Grown at 65.34%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest
Highest at CNY 20.44 MM
in the last five periods and Increased by 65.34% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Non Operating Income
Highest at CNY 0.1 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
